Global Pain Management Drugs Market Demand and Pipeline Insights (2022 Edition) – Analysis By Drug Type, Route of Administration, End-Use, Availability, Sales Channel, By Region, By Country: Market Insights & Forecast with Impact of COVID-19 (2023-2028)

Global Pain Management Drugs Market Demand and Pipeline Insights (2022 Edition) – Analysis By Drug Type, Route of Administration, End-Use, Availability, Sales Channel, By Region, By Country: Market Insights & Forecast with Impact of COVID-19 (2023-2028)

Executive Summary

According to Azoth Analytics research report published in September 2022, the global Pain Management Drugs market was valued at USD 82.12 million in the year 2021 with Americas leading the regional market share.

The global Pain Management Drugs Market is driven by an increasing number of Chronic Pain diseases and the prevalence of cancer pain worldwide. Additionally, a growing population in which the number of geriatric population is high in several developing countries is anticipated to propel the growth of the global Pain Management drugs market.

Additionally, life expectancy has increased due to various healthcare reforms in major economies such as the U.S., Japan, and China. This is likely to drive demand for many Pain Management drugs for advanced stages of cancer, chronic pain conditions and post-operative pain management drugs.

The COVID- 19 pandemic had a mixed impact on the Global Pain Management Drugs market by affecting the drug supply chain dramatically which led to hindrances in the production and sale of opiates which are the most prominent Pain management drug in the market in key producing countries such as Afghanistan and Myanmar. Paracetamol was recommended for use by various healthcare authorities across the world, to manage fever and mild pain in adults and children with COVID-19, which boosted the demand for the drug. Moreover, India and China being the chief API suppliers for Paracetamol drugs were unable to supply the APIs due to restrictions imposed due to COVID -19 which led to manufacturing restraints and shortages in many European countries.

Scope of the Report

  • The report presents insights on the 28 major drug development pipelines for Pain Management.
  • The report presents the analysis of the Pain Management Drugs Market for the historical period of 2018-2021, the estimated year 2022 and the forecast period of 2023-2028.
  • The report analyses the Pain Management Drugs Market by Drug Type (Acetaminophen, Nonsteroidal anti-inflammatory drugs (NSAIDs), Narcotics, Others).
  • The report analyses the Pain Management Drugs Market by Route of Administration (Topical, Intravenous, Oral, Others).
  • The report analyses the Pain Management Drugs Market by End-use (Inflammation, Neuropathic Pain, Musculoskeletal Pain, Severe and Chronic Pain).
  • The report analyses the Pain Management Drugs Market by Availability (Over the Counter (OTC), Prescription).
  • The report analyses the Pain Management Drugs Market by Sales Channel (Retail Pharmacies, Hospital Pharmacies and E-commerce).
  • The Global Pain Management Drugs Market has been analysed By Region (Americas, Europe, Asia Pacific, and MEA).
  • The Global Pain Management Drugs Market has been analysed By Country (United States, Canada, Germany, U.K, France, Spain, Italy, China, Japan and India).
  • The key insights of the report have been presented through the leading company shares. Also, the attractiveness of the market has been presented by region, by Drug Class, by Indication, by End User, by Formulation, and by Distribution Channel.
  • Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
  • The report tracks competitive developments, strategies, and recent developments. The companies analysed in the report include Pfizer, Johnson and Johnson, GSK Plc., Bristol-Myers Squibb, AbbVie, Bayer, Boehringer Ingelheim, Novartis, Teva Pharmaceutical, Sanofi, Amgen.
Key Target Audience
  • Pain Management Drugs Companies
  • Healthcare and Pharmaceutical Companies
  • Research and Development (R&D) Organizations
  • Government Bodies & Regulating Authorities
  • Investment Banks and Equity Firms


1. Report scope & Methodology
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary
2. Strategic Recommendations
2.1 Promotion of Abuse Deterrent Drugs
2.2 Development of Novel Analgesics using Nanomedicine technology
3. Global Pain Management Drugs Market: Product Overview
4. Global Pain Management Drugs Market:Pipeline Analysis
4.1. Competitive Positioning of Prominent companies with Pain management Drugs in their Pipeline
4.2 Investigational New Drug
4.2.1 Basimglurant (NOE-101), Drug Description and Outcomes
4.3 Phase I
4.3.1 Resiniferatoxin (RTX), Drug Description and Outcomes
4.3.2 VX-548, Drug Description and Outcomes
4.4 Phase - II/III
4.4.1 TLC590, Bupivacaine, Drug Description and Outcomes
4.5 Phase II
4.5.1 BAY2395840, Drug Description and Outcomes
4.5.2 Libvatrep- SAF312, Drug Description and Outcomes
4.5.3 Trametinib, Drug Description and Outcomes
4.5.4 Canakinumab + LNA043, Drug Description and Outcomes
4.5.5 Erenumab-aooe (EREN), Drug Description and Outcomes
4.5.6 Erenumab-Aooe (AimovigÆ), Drug Description and Outcomes
4.5.7 Erenumab-Aooe 70 MG, Drug Description and Outcomes
4.5.8 BOTOX (onabotulinumtoxinA), Drug Description and Outcomes
4.5.9 Resiniferatoxin, Drug Description and Outcomes
4.5.10 Resiniferatoxin, Zilretta, Drug Description and Outcomes
4.5.11 LY3526318, Drug Description and Outcomes
4.5.12 LY3526318, Drug Description and Outcomes
4.5.13 Quinagolide (FE 999051), Drug Description and Outcomes
4.5.14 HMI-115, Drug Description and Outcomes
4.6 Phase III
4.6.1 Secukinumab, Drug Description and Outcomes
4.6.2 Venglustat (GZ402671), Drug Description and Outcomes
4.6.3 Elagolix + Estradiol/Norethindrone Acetate, Drug Description and Outcomes
4.6.4 Elagolix + Combined Oral Contraceptive (COC), Drug Description and Outcomes
4.6.5 Ibuprofen PR (300 mg and 200 mg), Drug Description and Outcomes
4.6.6 Ibuprofen Liquid Capsules (200 mg), Drug Description and Outcomes
4.6.7 Intravenous (IV) tramadol (AVE-901), Drug Description and Outcomes
4.7 Phase IV
4.7.1 Catapresan, Drug Description and Outcomes
4.7.2 Ubrogepant 50 MG, 100MG, Drug Description and Outcomes Galcanezumab, Drug Description and Outcomes Erenumab Prefilled Syringe, Drug Description and Outcomes
5. Global Pain Management Drugs Market: An Analysis
5.1. Assessment of Macro-Economic Indicators of Global Pain Management Drugs Market
Table 1: Global Urban Population (2016-2020) (% of total)
Table 2: Global Aged Population (Above 65), 2015-20 (% of total Population)
Table 3: Global Aged Population(Above 65), By Country, 2020 (% of total Population)
Table 4: Global Medical Spending in 2020, By Region, (% of Total)
Table 5: Total number of hospitals in select countries worldwide in 2019-20
Table 6: Current Healthcare Expenditure (% Share of GDP), By Selected Country, 2016-2020 (In %)
Table 7: Estimated global prevalence and numbers of adults living with obesity (Obesity (Class I, II and III) BMI =30kg/m2 in 2010 -2030
Table 8: Age-adjusted comparative prevalence of diabetes, % (2000-2045)
Table 9: Global Expected Healthcare Industry Outlook
Table 10: Regional Expected Healthcare Industry Growth Rate By Year 2024
5.2. Pain Management Drugs Market
5.3 Market Size, By Value, 2018-2028
Table 11: Global Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
5.4 Global Pain Management Drugs Market: Growth and Forecast
Table 12: Global Estimated number of Cancer Types with high prevalence of pain (incidences and prevalent cases)(all ages, in millions), Year 2019
Table 13: Global Incidence of Road injuries,(in Millions), 2019
Table 14: Incidence of Injury from Fire, heat, and hot substances (In million), Year 2019
5.5 Impact of COVID-19 on Global Pain Management Drugs Market
6. Global Pain Management Drugs Market: Segment Analysis By Drug Type
6.1 Global Pain Management Drugs Market Segmentation, By Drug Type
6.2 Competitive Positioning of Pain Management Drugs Market: By Drug Type (2021 & 2028)
Table 15: Global Pain Management Drugs Market- By Drug Type, Market Share, 2021 & 2028
6.3 By Acetaminophen, By Value (USD Million), 2018-2028
Table 16: Global Pain Management Drugs Market- By Drug Type, By Acetaminophen (USD Million), 2018-2028
6.4 By NSAIDs, By Value (USD Million), 2018-2028
Table 17: Global Pain Management Drugs Market- By Drug Type, By NSAIDs, By Value (USD Billion), 2018-2028
6.5 By Narcotics (opioids), By Value (USD Million), 2018-2028
Table 18: Global Pain Management Drugs Market- By Drug Type, By Narcotics (opioids), By Value (USD Billion), 2018-2028
6.6 By Others, By Value (USD Million), 2018-2028
Table 19: Global Pain Management Drugs Market- By Drug Type, By Others, By Value (USD Billion), 2018-2028
7. Global Pain Management Drugs Market: Segment Analysis By Route of Administration
7.1 Global Pain Management Drugs Market Segmentation, By Route of Administration
7.2 Competitive Positioning of Pain Management Drugs Market: By Route of Administration (2021 & 2028)
Table 20: Global Pain Management Drugs Market- By Route of Administration Market Share, 2021 & 2028
7.3 By Topical, By Value (USD Million), 2018-2028
Table 21: Global Pain Management Drugs Market- By Route of Administration, By Topical Route (USD Billion), 2018-2028
7.4 By Intravenous, By Value (USD Million), 2018-2028
Table 22: Global Pain Management Drugs Market- By Route of Administration, By Intravenous Route (USD Billion), 2018-2028
7.5 By Oral, By Value (USD Million), 2018-2028
Table 23: Global Pain Management Drugs Market- By Route of Administration, By Oral Route (USD Billion), 2018-2028
7.6 By Others, By Value (USD Million), 2018-2028
Table 24: Global Pain Management Drugs Market- By Route of Administration, By Others (USD Billion), 2018-2028
8. Global Pain Management Drugs Market: Segment Analysis By End Use
8.1 Global Pain Management Drugs Market Segmentation, By End Use
8.2 Competitive Positioning of Pain Management Drugs Market: By End Use (2021 & 2028)
Table 25: Global Pain Management Drugs Market- By End use, Market Share, 2021 & 2028
8.3 By Inflammation, By Value (USD Million), 2018-2028
Table 26: Global Pain Management Drugs Market- By End use, By Inflammation, By Value (USD Billion), 2018-2028
8.4 By Neuropathic Pain, By Value (USD Million), 2018-2028
Table 27: Global Pain Management Drugs Market- By End use, By Neuropathic Pain, By Value (USD Billion), 2018-2028
8.5 By Musculoskeletal Pain, By Value (USD Million), 2018-2028
Table 28: Global Pain Management Drugs Market- By End use, By Musculoskeletal Pain, By Value (USD Billion), 2018-2028
8.6 By Severe and Chronic Pain, By Value (USD Million), 2018-2028
Table 29: Global Pain Management Drugs Market- By End use, By Severe and Chronic Pain, By Value (USD Billion), 2018-2028
9. Global Pain Management Drugs Market: Segment Analysis By Availability
9.1 Global Pain Management Drugs Market Segmentation, By Availability
9.2 Competitive Positioning of Pain Management Drugs Market: By Availability (2021 & 2028)
Table 30: Global Pain Management Drugs Market- By Availability Market Share, 2021 & 2028
9.3 By Prescription, By Value (USD Million), 2018-2028
Table 31:Global Pain Management Drugs Market- By Availability, By Prescription (USD Billion), 2018-2028
9.4 By Over The Counter (OTC), By Value (USD Million), 2018-2028
Table 32:Global Pain Management Drugs Market- By Availability, By Over The Counter (OTC), By Value (USD Billion), 2018-2028
10. Global Pain Management Drugs Market: Segment Analysis By Sales Channel
10.1 Global Pain Management Drugs Market Segmentation, By Sales Channel
10.2 Competitive Positioning of Pain Management Drugs Market: By Sales Channel (2021 & 2028)
Table 33: Global Pain Management Drugs Market- By Sales Channel Market Share, 2021 & 2028
10.3 By Hospital Pharmacies, By Value (USD Million), 2018-2028
Table 34: Global Pain Management Drugs Market- By Sales Channel, By Hospital Pharmacies, By Value (USD Billion), 2018-2028
10.4 By Retail Pharmacies, By Value (USD Million), 2018-2028
Table 35: Global Pain Management Drugs Market- By Sales Channel, By Retail Pharmacies, By Value (USD Billion), 2018-2028
10.5 By E-commerce, By Value (USD Million), 2018-2028
Table 36: Global Pain Management Drugs Market- By Sales Channel, By E-commerce, By Value (USD Billion), 2018-2028
11. Global Pain Management Drugs Market: Regional Analysis
11.1 Competitive Positioning of Global Pain Management Drugs Market: By Region (2021 & 2028)
Table 37: Global Pain Management Drugs Market- By Region Market Share, 2021 & 2028
12. Americas Pain Management Drugs Market: An Analysis (2018-2028)
12.1 Assessment of Macro-Economic Indicators of Americas Pain Management Drugs Market
Table 38: North America Population (in Millions), 2018-2021
Table 39: North America Population ages 65 and above (% of total Population), 2016-2020
Table 40: North America Current health expenditure per capita (current USD), 2015-19
Table 41: Latin America Population (in Millions), 2018-2021
Table 42: Incidence of Cancer in North and South America, (in million), 2020
Table 43: Incidence of Road injuries in Region of the Americas, (in million), 2016-2019
Table 44: Incidence of injuries from Fire, heat, and hot substances in Region of Americas, 2016-2019, (in millions)
Table 45: Prevalence of Osteoarthritis in Region of Americas, 2015-2019, (in millions)
Table 46: Prevalence of Diabetes in Regions of America, (in million), 2021
Table 47: Incidence of Appendicitis in Region of the Americas, (in million), 2016-2019
Table 48: Prevalence of chronic Low back and Neck Pain in Region of Americas, 2016-2019, (in millions)
12.2 Americas Pain Management Drugs Market- Size and Forecast, By Value (2018-2028)
Table 49: Americas Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
12.3 Americas Pain Management Drugs Market
12.4 Americas Pain Management Drugs Market: Prominent Companies
12.5 Americas Pain Management Drugs Market: Segment Analysis
12.6 Market Segmentation By Drug Type (Acetaminophen, Nonsteroidal anti-inflammatory drugs (NSAIDs) , Narcotics (opioids), Others) By Value
Table 50: Americas Pain Management Drugs Market- By Drug Type, By Value (USD Billion), 2018-2028
12.7 Market Segmentation By Route of Administration (Topical, Intravenous, Oral, Others) By Value
Table 51: Americas Pain Management Drugs Market- By Route of Administration, By Value (USD Billion), 2018-2028
12.8 Market Segmentation By End Use (Inflammation, Neuropathic Pain, Musculoskeletal Pain, Severe and Chronic Pain), By Value
Table 52: Americas Pain Management Drugs Market- By End-use, By Value (USD Billion), 2018-2028
12.9 Market Segmentation By Availability (OTC, Prescription), By Value
Table 53: Americas Pain Management Drugs Market- By Availability, By Value (USD Billion), 2018-2028
12.10 Market Segmentation By Sales Channel (Hospital pharmacies, retail pharmacies, e-commerce), By Value
Table 54: Americas Pain Management Drugs Market- By Sales Channel, By Value (USD Billion), 2018-2028
12.13 Americas Pain Management Drugs Market: Country Analysis
12.14 Market Opportunity Chart of Americas Pain Management Drugs Market - By Country, By Value (Year-2028)
Table 55: Market Opportunity Chart of Americas Pain Management Drugs Market- By Country, By Value (Year-2028)
12.15 Competitive Positioning of Americas Pain Management Drugs Market - By Country
Table 56: Americas Pain Management Drugs Market- By Country Market Share, 2021 & 2028
12.16 United States Pain Management Drugs Market: Size and Forecast (2018-2028)
Table 57: United States Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
12.17 United States Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End use, By Availability By Sales Channel (2018-2028)
Table 58: United States Pain Management Drugs Market- By Drug Type, By Value (USD Million), 2018-2028
Table 59: United States Pain Management Drugs Market- By Route of Administration, By Value (USD Billion), 2018-2028
Table 60: United States Pain Management Drugs Market- By End-use, By Value (USD Million), 2018-2028
Table 61: United States Pain Management Drugs Market- By Availability, By Value (USD Million), 2018-2028
Table 62: United States Pain Management Drugs Market- By Sales Channel, By Value (USD Million), 2018-2028
12.18 Canada Pain Management Drugs Market: Size and Forecast (2018-2028)
Table 63: Canada Pain Management Drugs Market Size, By Value, 2018-2028 (USD Million)
12.19 Canada Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End use, By Availability, By Sales Channel (2018-2028)
Table 64: Canada Pain Management Drugs Market- By Drug Type, By Value (USD Million), 2018-2028
Table 65: Canada Pain Management Drugs Market- By Route of Administration, By Value (USD Million), 2018-2028
Table 66: Canada Pain Management Drugs Market- By End-use, By Value (USD Million), 2018-2028
Table 67 : Canada Pain Management Drugs Market- By Availability, By Value (USD Million), 2018-2028
Table 68: Canada Pain Management Drugs Market- By Sales Channel, By Value (USD Million), 2018-2028
13. Europe Pain Management Drugs Market: An Analysis (2018-2028)
13.1 Assessment of Macro-Economic Indicators of Europe Pain Management Drugs Market
Table 69: European Union Population (in Millions), 2017-2020
Table 70: Population ages 65 and above (% of total Population) in European Countries, 2020
Table 71: European Union Current health expenditure per capita (current USD), 2015-19
Table 72: Total expenditure on health per capita in European countries (in USD PPP), 2019
Table 73: Incidence of Cancer in Europe, (in million), 2016-2019
Table 74: Incidence of Road Injuries in Europe, 2016-2019 (In Million)
Table 75: Incidence of Injuries from Fire, heat, and hot substances in Europe (all ages, in Million), Year 2016-2019
Table 76: Prevalence of Osteoarthritis Diseases in Europe, (in Million), 2015-2019
Table 77: Estimated Prevalence of Diabetes in Europe, (in million), 2011, 2021, 2030(E),2045(E)
Table 78: Incidence of Appendicitis in Europe, (in million), 2016-2019
Table 79: Prevalence of chronic Low back and Neck Pain in Europe, 2016-2019, (in millions)
13.2 Europe Pain Management Drugs Market By value: Size and Forecast (2018-2028)
Table 80: Europe Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
13.3 Europe Pain Management Drugs Market
13.4 Europe Pain Management Drugs Market: Prominent Companies
13.5 Europe Pain Management Drugs Market: Segment Analysis
13.6 Market Segmentation By Drug Type (Acetaminophen, Nonsteroidal anti-inflammatory drugs (NSAIDs) , Narcotics (opioids), Others) By Value
Table 81: Europe Pain Management Drugs Market- By Drug Type, By Value (USD Billion), 2018-2028
13.7 Market Segmentation By Route of Administration (Topical, Intravenous, Oral, Others) By Value
Table 82: Europe Pain Management Drugs Market- By Route of Administration, By Value (USD Billion), 2018-2028
13.4 Market Segmentation By End Use (Inflammation , Neuropathic Pain, Musculoskeletal Pain, Severe and Chronic Pain), By Value
Table 83: Europe Pain Management Drugs Market- By End-use, By Value (USD Billion), 2018-2028
13.5 Market Segmentation By Availability (OTC, Prescription), By Value
Table 84: Europe Pain Management Drugs Market- By Availability, By Value (USD Billion), 2018-2028
13.6 Market Segmentation By Sales Channel (Hospital pharmacies, retail pharmacies, e-commerce), By Value
Table 85: Europe Pain Management Drugs Market- By Sales Channel, By Value (USD Billion), 2018-2028
13.7 Europe Pain Management Drugs Market: Country Analysis
13.8 Market Opportunity Chart of Europe Pain Management Drugs Market - By Country, By Value (Year-2028)
Table 86: Market Opportunity Chart of Europe Pain Management Drugs Market- By Country, By Value (Year-2028)
13.9 Competitive Positioning of Europe Pain Management Drugs Market - By Country
Table 87: Europe Pain Management Drugs Market- By Country Market Share, 2021 & 2028
13.10 Germany Pain Management Drugs Market: Size and Forecast (2018-2028)
Table 88: Germany Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
13.11 Germany Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End use, By Availability, By Sales Channel (2018-2028)
Table 89: Germany Pain Management Drugs Market- By Drug Type, By Value (USD Billion), 2018-2028
Table 90: Germany Pain Management Drugs Market- By Route of Administration, By Value (USD Billion), 2018-2028
Table 91: Germany Pain Management Drugs Market- By End use, By Value (USD Billion), 2018-2028
Table 92: Germany Pain Management Drugs Market- By Availability, By Value (USD Billion), 2018-2028
Table 93: Germany Pain Management Drugs Market- By Sales Channel, By Value (USD Billion), 2018-2028
13.12 United Kingdom Pain Management Drugs Market: Size and Forecast (2018-2028)
Table 94: United Kingdom Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
13.13 United Kingdom Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End use, By Availability, By Sales Channel (2018-2028)
Table 95: United Kingdom Pain Management Drugs Market- By Drug Type, By Value (USD Billion), 2018-2028
Table 96: United Kingdom Pain Management Drugs Market- By Route of Administration, By Value (USD Billion), 2018-2028
Table 97: United kingdom Pain Management Drugs Market- By End-use, By Value (USD Billion), 2018-2028
Table 98: United Kingdom Pain Management Drugs Market- By Availability, By Value (USD Billion), 2018-2028
Table 99: United Kingdom Pain Management Drugs Market- By Sales Channel, By Value (USD Billion), 2018-2028
13.14 France Pain Management Drugs Market: Size and Forecast (2018-2028)
Table 100: France Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
13.15 France Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End use, By Availability, By Sales Channel (2018-2028)
Table 101: France Pain Management Drugs Market- By Drug Type, By Value (USD Billion), 2018-2028
Table 102: France Pain Management Drugs Market- By Route of Administration, By Value (USD Billion), 2018-2028
Table 103: France Pain Management Drugs Market- By End-use, By Value (USD Billion), 2018-2028
Table 104: France Pain Management Drugs Market- By Availability, By Value (USD Billion), 2018-2028
Table 105: France Pain Management Drugs Market- By Sales Channel, By Value (USD Billion), 2018-2028
13.16 Spain Pain Management Drugs Market: Size and Forecast (2018-2028)
Table 106: Spain Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
13.17 Spain Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End use, By Availability, By Sales Channel (2018-2028)
Table 107: Spain Pain Management Drugs Market- By Drug Type, By Value (USD Billion), 2018-2028
Table 108: Spain Pain Management Drugs Market- By Route of Administration, By Value (USD Billion), 2018-2028
Table 109: Spain Pain Management Drugs Market- By End-use, By Value (USD Billion), 2018-2028
Table 110: Spain Pain Management Drugs Market- By Availability, By Value (USD Billion), 2018-2028
Table 111: Spain Pain Management Drugs Market- By Sales Channel, By Value (USD Billion), 2018-2028
13.18 Italy Pain Management Drugs Market: Size and Forecast (2018-2028)
Table 112: Italy Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
13.19 Italy Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End use, By Availability, By Sales Channel (2018-2028)
Table 113: Italy Pain Management Drugs Market- By Drug Type, By Value (USD Billion), 2018-2028
Table 114: Italy Pain Management Drugs Market- By Route of Administration, By Value (USD Billion), 2018-2028
Table 115: Italy Pain Management Drugs Market- By End use, By Value (USD Billion), 2018-2028
Table 116: Italy Pain Management Drugs Market- By Availability, By Value (USD Billion), 2018-2028
Table 117: Italy Pain Management Drugs Market- By Sales Channel, By Value (USD Billion), 2018-2028
14 APAC Pain Management Drugs Market: An Analysis (2018-2028)
14.1 Assessment of Macro-Economic Indicators of APAC Pain Management Drugs Market
Table 118: Asia Pacific, Population ages 65 and above (% of total Population), 2016-20
Table 119: Asia Pacific Population ages 65 and above, By Countries (% of total Population), 2020
Table 120: Asia Pacific Current health expenditure per capita (current USD), 2014-18
Table 121: Asia Pacific, Current health expenditure per capita, By countries (current USD), 2019
Table 122: East Asia and Pacific Population (in Billion), 2018-2020
Table 123: Prevalence of Osteoarthritis Diseases in Asia Pacific, (in million), 2015-2019
Table 124: Incidence of Cancer in Asia, By countries (in million), 2020
Table 125: Incidence of Road Injuries in Asia, 2016-2019 (In Million)
Table 126: Estimated Prevalence of Diabetes in South-East Asia, (in million), 2011, 2021, 2030(E),2045(E)
Table 127: Incidence of Appendicitis in Asia, (in million), 2016-2019
Table 128: Prevalence of chronic Low back and Neck Pain in Europe, 2016-2019, (in millions)
Table 129: Incidence of Injuries from Fire, heat, and hot substances in Asia (all ages, in Million), Year 2016-2019
14.2 APAC Pain Management Drugs Market By value: Size and Forecast (2018-2028)
Table 130: Asia Pacific Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
14.3 APAC Pain Management Drugs Market
14.4 APAC Pain Management Drugs Market: Prominent Companies
14.5 APAC Pain Management Drugs Market: Segment Analysis
14.6 Market Segmentation By Drug Type (Acetaminophen, Nonsteroidal anti-inflammatory drugs (NSAIDs) , Narcotics (opioids), Others) By Value
Table 131: Asia Pacific Pain Management Drugs Market- By Drug Type, By Value (USD Billion), 2018-2028
14.7 Market Segmentation By Route of Administration (Topical, Intravenous, Oral, Others) By Value
Table 132 Asia Pacific Pain Management Drugs Market- By Route of Administration, By Value (USD Billion), 2018-2028
14.8 Market Segmentation By End Use (Inflammation, Neuropathic Pain, Musculoskeletal Pain, Severe and Chronic Pain), By Value
Table 133 Asia Pacific Pain Management Drugs Market- By End-use, By Value (USD Billion), 2018-2028
14.9 Market Segmentation By Availability (OTC, Prescription), By Value
Table 134 Asia Pacific Pain Management Drugs Market- By Availability, By Value (USD Billion), 2018-2028
14.10 Market Segmentation By Sales Channel (Hospital pharmacies, retail pharmacies, e-commerce), By Value
Table 135 Asia Pacific Pain Management Drugs Market- By Sales Channel, By Value (USD Billion), 2018-2028
14.11 APAC Pain Management Drugs Market: Country Analysis
14.12 Market Opportunity Chart of APAC Pain Management Drugs Market - By Country, By Value (Year-2028)
Table 136 Market Opportunity Chart of APAC Pain Management Drugs Market- By Country, By Value (Year-2028)
14.13 Competitive Positioning of APAC Pain Management Drugs Market - By Country
Table 137 APAC Pain Management Drugs Market- By Country Market Share, 2021 & 2028
14.14 China Pain Management Drugs Market: Size and Forecast (2018-2028)
Table 138 China Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
14.15 China Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End use, By Availability, By Sales Channel (2018-2028)
Table 139 China Pain Management Drugs Market- By Drug Type, By Value (USD Billion), 2018-2028
Table 140 China Pain Management Drugs Market- By Route of Administration, By Value (USD Billion), 2018-2028
Table 141 China Pain Management Drugs Market- By End-use, By Value (USD Billion), 2018-2028
Table 142: China Pain Management Drugs Market- By Availability, By Value (USD Billion), 2018-2028
Table 143: China Pain Management Drugs Market- By Sales Channel, By Value (USD Billion), 2018-2028
14.16 Japan Pain Management Drugs Market: Size and Forecast (2018-2028)
Table 144: Japan Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
14.7 Japan Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End use, By Availability, By Sales Channel (2018-2028)
Table 145: Japan Pain Management Drugs Market- By Drug Type, By Value (USD Billion), 2018-2028
Table 146: Japan Pain Management Drugs Market- By Route of Administration, By Value (USD Billion), 2018-2028
Table 147: Japan Pain Management Drugs Market- By End-use, By Value (USD Billion), 2018-2028
Table 148: Japan Pain Management Drugs Market- By Availability, By Value (USD Billion), 2018-2028
Table 149: Japan Pain Management Drugs Market- By Sales Channel, By Value (USD Billion), 2018-2028
14.8 India Pain Management Drugs Market: Size and Forecast (2018-2028)
Table 150: India Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
14.9 India Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End use, By Availability, By Sales Channel (2018-2028)
Table 151: India Pain Management Drugs Market- By Drug Type, By Value (USD Billion), 2018-2028
Table 152: India Pain Management Drugs Market- By Route of Administration, By Value (USD Billion), 2018-2028
Table 153: India Pain Management Drugs Market- By End-use, By Value (USD Billion), 2018-2028
Table 154: India Pain Management Drugs Market- By Availability, By Value (USD Billion), 2018-2028
Table 155: India Pain Management Drugs Market- By Sales Channel, By Value (USD Billion), 2018-2028
15. Middle East and Africa Pain Management Drugs Market
15.1 Assessment of Macro-Economic Indicators of MEA Pain Management Drugs Market
Table 156: Middle East and North Africa Population(in Million), 2018-2020
Table 157: Middle East and North Africa, GDP Per Capita, value (USD Million), 2018-2020
Table 158: Middle East and North Africa, Population ages 65 and above (% of the total population), 2016-19
Table 159: Middle East and North Africa, Incidence of Osteoarthritis (in millions), 2016-19
Table 160: Incidence of Cancer in AFRO, By countries (ASR per 100,000), 2020
Table 161: Incidence of Injuries from Fire, heat, and hot substances in North Africa and Middle East (all ages, in Million), 2016-2019
Table 162: Incidence of Road Injuries in North Africa and Middle East, 2016-2019 (In Million)
Table 163: Estimated Prevalence of Diabetes in Middle East and North Africa, (in million), 2011, 2021, 2030(E),2045(E)
Table 164: Incidence of Appendicitis in North Africa and Middle East, (in thousands), 2016-2019
Table 165: Prevalence of chronic Low back and Neck Pain in North Africa and Middle East , 2016-2019, (in millions)
15.2 Middle East and Africa Pain Management Drugs Market By value: Size and Forecast (2018-2028)
Table 166: Middle East and Africa Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
15.3 Market Segmentation By Drug Type (Antibiotics, Antifungals, Astringents, Antipruritic, Analgesics, Others)
Table 167: Middle East and Africa Pain Management Drugs Market- By Drug Type, By Value (USD Billion), 2018-2028
15.4 Market Segmentation By Route of Administration (Skin Disease, Pain Management, Eye and Ear Care, Others), By Value
Table 168: Middle East and Africa Pain Management Drugs Market- By Route of Administration, By Value (USD Billion), 2018-2028
15.5 Market Segmentation By End use (Inflammation, Neuropathic Pain, Musculoskeletal Pain, Others), By Value
Table 169: Middle East and Africa Pain Management Drugs Market- By End use, By Value (USD Billion), 2018-2028
15.6 Market Segmentation By Availability (Prescription, Over The Counter (OTC), Others), By Value
Table 170: Middle East and Africa Pain Management Drugs Market- By Availability, By Value (USD Billion), 2018-2028
15.7 Market Segmentation By Sales Channel (Hospital Pharmacies, Retail Pharmacies, Others), By Value
Table 171: Middle East and Africa Pain Management Drugs Market- By Sales Channel, By Value (USD Billion), 2018-2028
16. Global Pain Management Drugs Market Dynamics
16.1 Global Pain Management Drugs Market Drivers
16.2 Global Pain Management Drugs Market Restraints
16.3 Global Pain Management Drugs Market Trends
17. Market Attractiveness and Strategic Analysis
17.1 Market Attractiveness Chart of Global Pain Management Drugs Market - By Drug Type (2028)
Table 172: Market Attractiveness Chart of Global Pain Management Drugs Market- By Drug Type (2028)
17.2 Market Attractiveness Chart of Global Pain Management Drugs Market - By Route of Administration (2028)
Table 173: Market Attractiveness Chart of Global Pain Management Drugs Market- By Route of Administration (2028)
17.3 Market Attractiveness Chart of Global Pain Management Drugs Market - By End use (2028)
Table 174: Market Attractiveness Chart of Global Pain Management Drugs Market- By End use (2028)
17.4 Market Attractiveness Chart of Global Pain Management Drugs Market - By Availability (2028)
Table 175: Market Attractiveness Chart of Global Pain Management Drugs Market- By Availability (2028)
17.5 Market Attractiveness Chart of Global Pain Management Drugs Market - By Sales Channel (2028)
Table 176: Market Attractiveness Chart of Global Pain Management Drugs Market- By Sales Channel (2028)
17.6 Market Attractiveness Chart of Global Pain Management Drugs Market - By Region (2028)
Table 177: Market Attractiveness Chart of Global Pain Management Drugs Market- By Region (2028)
18. Competitive Landscape
18.1 Market Share of global leading companies
Table 178: Global Pain Management Drugs Market Share (%), 2021
19. Company Profiles (Business Description, Financial Analysis, Business Strategy)
19.1 Pfizer Inc.
Table 179: PFIZER Inc. Annual Sales Revenue, 2017-2021 (USD Million)
Table 180: PFIZER Inc. Net Income, 2017-2021 (USD Million)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings